BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24740818)

  • 1. Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression.
    Uehara H; Takahashi T; Oha M; Ogawa H; Izumi K
    Int J Cancer; 2014 Dec; 135(11):2558-68. PubMed ID: 24740818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.
    Li X; Song Y; Zhang P; Zhu H; Chen L; Xiao Y; Xing Y
    Tumour Biol; 2016 Jun; 37(6):7599-613. PubMed ID: 26687646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway.
    Li B; Tsao SW; Li YY; Wang X; Ling MT; Wong YC; He QY; Cheung AL
    Int J Cancer; 2009 Dec; 125(11):2576-85. PubMed ID: 19551863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FABP4 reversed the regulation of leptin on mitochondrial fatty acid oxidation in mice adipocytes.
    Gan L; Liu Z; Cao W; Zhang Z; Sun C
    Sci Rep; 2015 Aug; 5():13588. PubMed ID: 26310911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitic acid inhibits prostate cancer cell proliferation and metastasis by suppressing the PI3K/Akt pathway.
    Zhu S; Jiao W; Xu Y; Hou L; Li H; Shao J; Zhang X; Wang R; Kong D
    Life Sci; 2021 Dec; 286():120046. PubMed ID: 34653428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid binding protein 4 promotes epithelial-mesenchymal transition in cervical squamous cell carcinoma through AKT/GSK3β/Snail signaling pathway.
    Jin J; Zhang Z; Zhang S; Chen X; Chen Z; Hu P; Wang J; Xie C
    Mol Cell Endocrinol; 2018 Feb; 461():155-164. PubMed ID: 28893569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4.
    Nie J; Zhang J; Wang L; Lu L; Yuan Q; An F; Zhang S; Jiao Y
    J Exp Clin Cancer Res; 2017 Dec; 36(1):183. PubMed ID: 29237483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins.
    Guaita-Esteruelas S; Bosquet A; Saavedra P; Gumà J; Girona J; Lam EW; Amillano K; Borràs J; Masana L
    Mol Carcinog; 2017 Jan; 56(1):208-217. PubMed ID: 27061264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
    Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M
    Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.
    Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H
    Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
    Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
    Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy.
    Li B; Tsao SW; Chan KW; Ludwig DL; Novosyadlyy R; Li YY; He QY; Cheung AL
    Clin Cancer Res; 2014 May; 20(10):2651-62. PubMed ID: 24599933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma.
    Thompson KJ; Austin RG; Nazari SS; Gersin KS; Iannitti DA; McKillop IH
    Liver Int; 2018 Jun; 38(6):1074-1083. PubMed ID: 29171144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells.
    Bosquet A; Guaita-Esteruelas S; Saavedra P; Rodríguez-Calvo R; Heras M; Girona J; Masana L
    Atherosclerosis; 2016 Jun; 249():191-9. PubMed ID: 27155388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.